ArticleNanoscale advances2019

Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells.

S Avvakumova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.